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Abstract
Background: Long non-coding RNAs (lncRNAs) are emerging as new players in the cancer. The aim of this study
was to examine the abnormalities of NEAT1 (nuclear paraspeckle assembly transcript 1, also known as MENε/β) in
gastric adenocarcinomas (GACs).
Methods: One hundred thirty-one GAC tissues and matched adjacent normal tissues (ANTs) were collected from
patients who undergone surgery. Differences in of NEAT1 expression were examined via quantitative reverse
transcriptase PCR (qRT-PCR). WST-1 assay and transwell assay were carried out in vitro to investigate the
proliferation and migration of GAC cells with alteration in NEAT1 long non-coding RNA (lncRNA) expression.
Results: The expression levels of lncRNA NEAT1 were significantly elevated in GAC tissues (P < 0.001)
compared with ANTs. There was also a statistical difference in NEAT1 expression between early and advanced
GACs (P = 0.0111). GACs with lymph node metastasis (LNM) expressed higher levels of NEAT1 lncRNA
compared with those without LNM (P = 0.004). In the in vitro experiments, the proliferation but not migration
of GAC cells was attenuated after NEAT1 knockdown by RNA interference.
Conclusions: Expression of NEAT1 lncRNA was enhanced in GACs; and NEAT1 may influence GAC progression
by promoting tumor growth.
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Background
Gastric cancer (GC) is a major health burden through-
out the world. It is currently the most common cancer
in China, responsible for about 300,000 deaths per year
[1, 2]. GC is commonly diagnosed at an advanced stage
because of the lack of early detection strategies and is
usually associated with a dismal outcome [3, 4]. Most of
GCs are adenocarcinomas. The development of gastric
cancer is a complex, multistep process involving mul-
tiple genetic and epigenetic alterations of oncogenes,
tumor suppressor genes, DNA repair genes, cell cycle
regulators, and signaling molecules [5–7].
Recent studies have highlighted the role of a group of
long (>200 bp) non-coding RNAs (lncRNAs) in carcino-
genesis and suggested that this class of genes might be
used as biomarkers in cancer [8–10]. LncRNAs are perva-
sively transcribed in the genome and are emerging as new
players in tumorigenesis due to their various functions in
transcriptional, posttranscriptional, and epigenetic mecha-
nisms of gene regulation [11]. LncRNAs are dysregulated
in a number of cancers, in which they demonstrated both
oncogenic and tumor-suppressive roles. These evidences
suggested that lncRNAs’ aberrant expression might be a
substantial contributor in cancer development. Several
cancer-related long non-coding RNAs have been reported
to be correlated with GAC proliferation or metastasis, in-
cluding HOTAIR, ANRIL, MRUL, CCAT1, NEAT1 and
HULC, etc. [12, 13].
However, there is few report about the expression of
nuclear-enriched abundant transcript 1 (NEAT1)
lncRNA in GCs. NEAT1 is a novel long non-coding
RNA (lncRNA) which serves as a crucial regulator in
several cancers [14, 15]. NEAT1 had higher expression
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in the hepatocellular carcinoma (HCC), which pro-
moted the clinical features of HCC [16]. NEAT1 might
also be associated with tumorigenesis and progression
in non-small cell lung cancers (NSCLC) [17]. NEAT1
drove oncogenic growth in prostate cancer [18]. We
asked whether there were abnormalities of this
lncRNA in GCs.
In the present study, we examined the expression
levels of NEAT1 lncRNA in collected GAC and ANT
samples and found that the expression levels of NEAT1
lncRNA were significantly enhanced in GACs and had
an association with tumor stages. Knockdown of NEAT1
lncRNA led to impaired proliferation of GAC cells in
vitro.
Methods
Patients and tissue collection
GAC samples were obtained from 131 surgical patients
of the Department of Gastroenterology, Zhonghan
Hospital of Hubei Province. All 131 tumors were adeno-
carcinomas and other types of tumors (squamous cell,
carcinoid, and stromal tumors) were excluded. A sum-
mary of cohort characteristics was shown in Table 1.
Case-matched adjacent normal mucosa, located at least
3 cm far from the macroscopically unaffected margins of
the tumor, were defined as normal controls. All the sam-
ples were stored in liquid nitrogen immediately after the
operations. Gastric carcinomas were staged according to
the TN classification system and graded into five groups:
stage 0 (TisN0M0, n = 0), stage 1 (T1N0–1M0, n = 4),
stage 2 (T1N2M0, T2N0–1M0, n = 30), stage 3 (T2N2M0,
T3N1–2M0, T4N0M0, n = 66), stage 4 (T4N1–2M0,T1–
3N3M0, TanyNanyM1, n = 31). Matched samples of GACs
and adjacent normal tissues (ANTs) were immediately
stored in liquid nitrogen after operation. For each sample,
a portion of tissue was disposed to make frozen sections
and then micro-dissected by the Eppendorf Microdissec-
tion System (Siskiyou MX160L micromanipulator and
PixeLink PL-A662 color CCD firewire camera). Then, the
dissected tissues were subjected to real-time PCR analysis.
All patients were informed about the aims of specimen
collection and gave signed written consent in accordance
with the ethical guidelines of Zhongshan University. The
investigations were conducted according to the Declar-
ation of Helsinki principles and the study was approved by
the ethical committee of Zhongshan Hospital of Hubei
Province (EC201402348).
RNA extraction and real-time PCR
Total RNA was isolated from tissues by using AxyPrepTM
Blood Total RNA MiniPrep Kit (Axygen) according to the
manufacturer’s instruction. First-strand complementary
DNA (cDNA) was synthesized with RevertAid™ First
Stand cDNA Synthesis Kit (Fermentas) using a random
hexamar primer. Quantitative PCR was performed
through BioRad Chromo4 real-time PCR system. The pri-
mer sets for amplifying NEAT1 and reference gen (ACTB)
are the following: NEAT1-F: TGG ACT AGCT CAG
GGA CTT CAG; NEAT1-R: TCT CCT TGA CCA AGA
CTT CCT TC; ACTB-F: GAC CTG ACT GAC TAC
CTC ATG AAG AT; ACTB-R: GTC ACA CTT CAT
GAT GGA GTT GAA GG. At the end point of PCR cy-
cles, melt curves were made to check product purity. The
level of NEAT1 was expressed as a ratio relative to the β-
actin messenger RNA (mRNA) in each sample. Explora-
tory data analysis using scatter plot was applied to visually
identify the expression level of target mRNA. Statistical
analysis was performed using paired t test or non-
parametric test. P values less than 0.05 were considered
statistically significant.
Cell culture
Human gastric cancer cell lines MKN-45, BGC823,
MGC803, SGC7901, AGS, and MKN28 were obtained
from the Cobioer Biosciences Co., Ltd. (Shanghai, China)
where they were characterized by mycoplasma detection,
DNA fingerprinting, isozyme detection, and cell vitality
detection. These cell lines were purchased in August 2014
and immediately expanded and frozen such that they
could be restarted every 3 to 4 months from a frozen vial
of the same batch of cells. MKN28 cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco) sup-
plemented with 10 % fetal bovine serum (PAA) and 1 %
penicillin/streptomycin (Life Technologies, Inc.).
Reagents and cell transfection
Lipofectamine 2000 transfection reagent (Invitrogen,
Carlsbad, CA, USA) was used. The pcDNA3.1-NEAT1
and empty vector (used as a negative control) was pur-
chased from Invitrogen, Shanghai, China. Cells were
seeded in 96 plates 24 h before the experiment.
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MGC803 cells were transfected with pcDNA3.1-NEAT1
or negative control. The MGC803 was transfected.
NEAT1 knockdown by lentiviruses
NEAT1-set small interfering RNA (siRNA)/small hairpin
RNA (shRNA)/RNAi Lentivector as well as control shRNA
vector were purchased from Nanjing EnoGene Biotechnol-
ogy Limited Corporation (catalog no. ES000103). To gener-
ate lentiviruses expressing MALAT-1 shRNA and control
shRNAs, HEK293T cells grown on a 10-cm dish were
transfected with 6 μg of NEAT1-set shRNA lentivector or
control vector, 6 μg of pREV, 6 μg of pGag/Pol, and 2 μg of
pVSVg. Twelve hours after transfection, cells were cultured
with DMEM medium containing 20 % FBS for an add-
itional 36 h. The culture medium containing lentivirus par-
ticles was centrifuged at 10,000 ×g for 2 min and then used
for infection. Twenty-four hours after infection, cells were
cultured with fresh medium for another 24 h, followed with
further experiment. The knockdown efficiency was evalu-
ated by real-time PCR analysis.
Cell proliferation assay
Cell proliferation was measured by WST-1 assay. Cells were
plated in 96-well culture plates (1 × 103 per well); WST-1
(Roche) assay measuring the activity of mitochondrial dehy-
drogenases was performed following the manufacturer’s
instruction at 0-, 1-, 2-, 3-, 4-, and 5-day time points.
Cell migration assay
Migration assays were performed using 24-well transwell
units with 8-mm pore size polycarbonate inserts (BD
Biosciences). Transwells were coated overnight with
10 mg/mL of fibronectin in phosphate-buffered saline at
48.8 °C, followed by incubation with 1 % bovine serum
albumin for 1 h at 37 °C. The MKN45 and AGS cells
transfected with NEAT1 shRNA or nonsense strand were
detached with trypsin/ethylene diamine tetraacetic acid,
washed once with DMEM containing 10 % fetal bovine
serum (FBS), and re-suspended in DMEM containing 1 %
FBS at 2 × 105 cells/mL. Aliquots (100 mL) of cell suspen-
sions were directly added to the upper side of each cham-
ber. Following incubation for 12 h, the cells on the upper
side of the membrane were removed, whereas the cells
that migrated to the underside were fixed with 3 % formal-
dehyde and stained with 0.3 % crystal violet for 10 min.
The number of cells on the underside of the membrane
was counted in five different fields with a light microscope
at 20 °C, and the mean and standard deviation were calcu-
lated from three independent experiments.
Statistical analysis
GraphPad Prism software (Version 5.0) was used to
analyze the obtained data. Results of the NEAT1 lncRNA
expression for paired GACs and ANTs or paired GACs
and local lymph node metastases were compared using
paired t test. Results of the NEAT1 lncRNA expression in
different GAC groups were compared using non-
parametric Mann–Whitney test. P values less than 0.05
were considered statistically significant.
Results
Increased expression of NEAT1 lncRNA in GACs
The expression levels of NEAT1 lncRNA in the collected
GAC samples were examined using real-time PCR assay.
As shown in Fig. 1a, the expression levels of NEAT1
lncRNA were markedly enhanced in GACs compared to
ANTs (P < 0.001). There was a statistical difference be-
tween the group of early-stage GACs and advanced
GACs (P < 0.01). This result was in line with the re-
ported findings in NSCLCs and HCCs [16, 17].
Fig. 1 Enhanced expression of NEAT1 lncRNA in GAC. Real-time PCR assay was carried out as described under the “Methods” section, and the results
were obtained from indicated group of samples. a Scatter plot illustrated the relative expression of indicated lncRNAs as a ratio of lncRNA to β-actin
mRNA in each sample. b Scatter plot illustrated the relative expression of NEAT1 as a ratio of GAC to ANT mRNA (GAC/ACTB: ANT/ACTB) in
each sample
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An association between NEAT1 expression and lymph
node metastasis
Next, we compared the NEAT1 lncRNA expression be-
tween tumor groups with (n = 85) or without lymph
node metastasis (n = 46). As shown in Fig. 2a, there was
a marked difference of NEAT1 expression between GAC
with or without lymph node metastasis (LNM) (P =
0.004). In the GACs with LNM (n = 85), we also com-
pared the expression of NEAT1 lncRNA in primary tu-
mors and metastases. As shown in Fig. 2b, the analysis
using paired t test showed a minor but significant in-
crease of NEAT1 lncRNA expression in the metastases
compared to the corresponding primary tumors (P =
0.0392). The association between NEAT1 expression and
GAC metastasis might need further investigation.
Increased expression of NEAT1 lncRNA promotes growth
of GAC cells in vitro
It was reported that increased NEAT1 lncRNA expres-
sion could drive oncogenic growth by altering the epi-
genetic landscape of target gene promoters to favor
transcription [18]. To further investigate the role of
NEAT1 lncRNA in GAC progression, in vitro studies
using GAC cell lines were performed. We first compared
the expression of NEAT1 lncRNA among six cell lines
including MKN45, BGC823, MGC803, SGC7901, AGS,
and MKN28. As shown in Fig. 3a, MKN-45 and AGS
showed relatively higher expression of NEAT1, which
were utilized for the following knockdown experiments.
The efficiencies of overexpression and knockdown of
NEAT1 in GAC cells were shown in Fig. 3b, c. Then,
WST-1 assay was carried out to evaluate the influence of
altered expression of NEAT1 on GAC cell proliferation.
As shown in Fig. 3d, down-regulation of NEAT1
lncRNA significantly impaired the proliferation of
MKN45 and AGS cells, while overexpression of NEAT1
lncRNA resulted in enhanced proliferation in MGC803
cells.
The migration ability of MKN45 and AGS cells trans-
fected with NEAT1 shRNA or scramble RNA was evalu-
ated by transwell assay. We found that the MKN45 as
well as AGS cells with decreased expression of NEAT1
showed slightly impaired migration compared with con-
trols (Fig. 3e). Thus, altered expression NEAT1 lncRNA
might have minor effect on GAC cells’ migration.
Discussion
LncRNA contributes significantly to human transcrip-
tome and plays a critical role in cancer development
[19]. Here, we focused on the expression of NEAT1
lncRNA in GACs and used a large number of cases in
the current study to find a novel correlation between el-
evated expression of NEAT1 lncRNA and GAC patho-
genesis. We also found that advanced GACs had a
higher expression of NEAT1 lncRNA than those at early
stages, which indicated potential role of NEAT1 abnor-
malities in GAC progression. A marked difference was
observed between GACs with and without LNM, indi-
cating a possible role of NEAT1 lncRNA in the metasta-
sis of GACs. However, in the GAC cases with LNM, the
metastases of GACs showed only minor NEAT1 eleva-
tion compared to the primary tumors. Thus, the role of
NEAT1 lncRNA in the metastasis of GACs needs further
investigation.
The key feature of non-coding RNAs (ncRNAs) is that
they are not translated into proteins but rather function
directly at the RNA level [20, 21]. To investigate the role
of NEAT1 abnormalities in GAC, we performed in vitro
Fig. 2 Higher expression of NEAT1 in GAC with lymph node metastasis. a Scatter plot illustrated the relative expression of NEAT1 as a ratio of
GAC to paired ANT in the GACs with or without lymph node metastasis. b Scatter plot illustrated the relative expression of NEAT1 as a ratio of
GAC to paired ANT in the primary tumors and lymph node metastases
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Fig. 3 Knockdown of NEAT1 lncRNA impairs growth of GAC cells in vitro. a Expression levels of NEAT1 lncRNA were examined by real-time PCR.
b The expressions of NEAT1 mRNA in MGC803 cells transfected with pcDNA3-NEAT1 and control vector detected by RT-qPCR. c After treatment
of lentiviruses expressing NEAT1 shRNA and control shRNAs, the expression levels of NEAT1 lncRNA were examined by real-time PCR. The relative
expression of NEAT1 lncRNA (as the ratio of NEAT1 lncRNA to β-actin mRNA) is illustrated as a ratio to control (cells transfected with control
shRNA). d WST-1 (Roche) assay measuring the activity of mitochondrial dehydrogenases was performed following the manufacturer’s instruction
at 0-, 1-, 2-, 3-, and 4-day time points. Error bars represent the standard deviation of the mean. e Cell migration was determined using a transwell
assay as described in the “Methods” section. Microscopic image of migrated MKN45 and AGS cells, cells transfected with nonsense strand or
NEAT1 shRNA, respectively. Original magnification 200×. The diagrams of migrating cells from the different transfectants are also shown, which
come from more than three independent experiments
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studies to examine the influences of altered NEAT1 ex-
pression on proliferation and migration of GAC cells.
We found that knockdown of NEAT1 lncRNA led to a
significant impairment of growth in GAC cells, while it
had little influence on migration of GAC cells in vitro.
These indicate that overexpression of NEAT1 lncRNA in
GAC might mainly regulate the genes that correlated
with cell growth but not the genes associated with can-
cer metastasis. These were not fully in accordance with
the previous findings in NSCLC [17] or HCC [16], in
which the proliferative, migrational, and invasive behav-
iors of cancer cells were all enhanced by exogenous
NEAT1 expression in vitro. This discrepancy might be
explained by the different expression pattern of mRNAs
that were influenced by NEAT1 in various types of can-
cer. And the mRNAs that were regulated by NEAT1
lncRNA in GAC need to be further investigated using
high-throughput assays like microarrays and RNA
sequencing.
In conclusion, our findings suggest that the expression
level of NEAT1 has the potential to predict GAC progres-
sion. However, the functional consequences of altered
NEAT1 expression and the underlying mechanisms of the
heterogeneous expression levels in GACs need to be fur-
ther investigated in the future.
Conclusions
Here, we report a novel finding about the abnormal
NEAT1 lncRNA expression in gastric adenocarcinomas
(GACs). Our study indicated that increased expression
of NEAT1 lncRNA in GACs correlated with tumor stage
as well as lymph node metastasis in clinical GAC sam-
ples. Knockdown of NEAT1 lncRNA in GAC cells led to
impaired growth. Thus, we conclude that enhanced
NEAT1 lncRNA may play a role in the progression of
GAC pathogenesis.
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